Athos Capital’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Athos Capital’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-410,389	Closed	-$4.6M	–	38
2017 Q3	$4.6M	Buy	410,389 +126,189	+44%	+$1.39M	3.46%	10
2017 Q2	$3.13M	Buy	+284,200	New	+$2.84M	1.8%	16

Athos Capital's SCLN Position: Q4 2017 in Review

Athos Capital sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 410,389 shares — an estimated $4.6M sold.

Athos Capital first reported a position in SCLN in Q2 2017 and held it in 2 quarters. The position peaked at $4.6M in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

Athos Capital reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Athos Capital sold 410,389 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $4.6M.
Athos Capital first reported a position in Sciclone Pharmaceuticals Inc in Q2 2017 and held it in 2 quarters.
Athos Capital's Sciclone Pharmaceuticals Inc position peaked at $4.6M in Q3 2017.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Athos Capital's 13F filing for Q4 2017, filed 9 Feb 2018.